Paul Tudor Jones Ngm Biopharmaceuticals Inc Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 25,147 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,147
Previous 25,147
-0.0%
Holding current value
$0
Previous $21,000
85.71%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NGM
# of Institutions
77Shares Held
36.8MCall Options Held
1.1KPut Options Held
200-
Column Group LLC San Francisco, CA18.1MShares$017.97% of portfolio
-
Black Rock Inc. New York, NY3MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$00.0% of portfolio
-
Step Stone Group LP La Jolla, CA1.57MShares$00.6% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA1.3MShares$044.41% of portfolio
About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...